A detailed history of Schonfeld Strategic Advisors LLC transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 386,584 shares of LIFE stock, worth $719,046. This represents 0.01% of its overall portfolio holdings.

Number of Shares
386,584
Previous 38,900 893.79%
Holding current value
$719,046
Previous $60,000 1098.33%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.24 $525,002 - $778,812
347,684 Added 893.79%
386,584 $719,000
Q2 2024

Aug 14, 2024

BUY
$0.0 - $2.07 $0 - $38,088
18,400 Added 89.76%
38,900 $60,000
Q1 2024

May 15, 2024

BUY
$1.42 - $2.02 $29,110 - $41,410
20,500 New
20,500 $39,000
Q2 2023

Aug 14, 2023

BUY
$1.72 - $2.57 $19,092 - $28,527
11,100 New
11,100 $23,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.